Global Left Atrial Appendage (LAA) Closure Market 2016-2020

左心耳(LAA)閉鎖デバイスの世界市場2016-2020

◆タイトル:Global Left Atrial Appendage (LAA) Closure Market 2016-2020
◆商品コード:IRTNTR7702
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年12月9日
◆ページ数:57
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、左心耳(LAA)閉鎖デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、左心耳(LAA)閉鎖デバイスの世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

The left atrial appendage (LAA) is a small ear-shaped sac in the muscle wall of the top left chamber of the heart that controls the electrical impulses during atrial fibrillation. LAA closure device is an interventional device used to prevent stroke, reduce the risk of secondary stroke and emboli because of atrial fibrillation. The global left atrial appendage closure market is expected to grow at a massive CAGR of over 28% during the forecast period.

Numerous factors drive the left atrial appendage closure market, but one of the main factors is the significant increase in the incidences of stroke. It is estimated that around 15 million people suffer a stroke every year across the globe. With the rise in the aging population, excessive smoking, average hypertension, and cholesterol levels, the number of atrial fibrillation cases is also increasing globally.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

• Epicardial LAA closure device
• Endocardial LAA closure device

Endocardial involves implantation of a device to occlude the LAA. Endocardial LAA closure devices are implanted through a transseptal approach under TEE technique. A specific delivery system has been developed for each device type allowing for repositioning, collapse, or removal in the event of suboptimal results.

The EMEA region is the highest revenue generator in the left atrial appendage closure market in 2015, accounting for about 52% share, and then followed by the APAC region. The market in the EMEA is expected to continue its growth during the forecast period and this is attributed to increase in the incidence of strokes and the growing elderly population. Stroke alone accounts for 1.1 million deaths in Europe every year.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
• Americas
• APAC
• EMEA

The LAA closure market witness the presence of very few market vendors, hence the competition in the market is moderate at present. However, the competition is expected to intensify with new product launches. Also, there is a vast opportunity for the market to grow significantly in the Americas in the forecast period.

Primary vendors in this market are:
• AtriCure
• Boston Scientific
• St. Jude
• Coherex Medical

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Pipeline analysis

PART 07: Regulation of LAA closure devices

PART 08: Market segmentation by product

PART 09: Geographical segmentation
• Left atrial appendage closure market in Americas
• Left atrial appendage closure market in EMEA
• Left atrial appendage closure market in APAC

PART 10: Market drivers
• Increasing incidences of stroke
• Potential long-term cost-effectiveness of LAA closure devices
• Rise in aging population

PART 11: Impact of drivers

PART 12: Market challenges
• Complicated LAA closure implantation procedure
• Stringent regulation for approval of device and product recalls
• High acceptance of warfarin and dabigatran

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Focus on clinical trials
• Increase in awareness programs
• Significant growth in US

PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2014
• Other prominent vendors

PART 16: Key vendor analysis
• AtriCure
• Boston Scientific
• St. Jude
• Coherex Medical

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global left atrial appendage closure market 2015-2020 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Pipeline analysis snapshot of LAA closure device
Exhibit 05: Snapshot for regulation of medical devices
Exhibit 06: Timeline of key events – Watchman device regulations
Exhibit 07: Segmentation of LAA closure by product
Exhibit 08: Segmentation of global left atrial appendage closure market by geography 2015
Exhibit 09: Segmentation of global left atrial appendage closure market by geography 2020
Exhibit 10: Segmentation of global left atrial appendage closure market by geography 2015-2020
Exhibit 11: Left atrial appendage closure market in Americas 2015-2020 ($ millions)
Exhibit 12: Left atrial appendage closure market in EMEA 2015-2020 ($ millions)
Exhibit 13: Left atrial appendage closure market in APAC 2015-2020 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Key takeaways: Boston Scientific
Exhibit 17: Key takeaways: St. Jude Medical
Exhibit 18: Key takeaways: AtriCure
Exhibit 19: Key takeaways: Coherex Medical
Exhibit 20: AtriCure: Product categories
Exhibit 21: AtriCure: Geographical segmentation by revenue 2014
Exhibit 22: Boston Scientific: Business segmentation by revenue 2014
Exhibit 23: Boston Scientific: Business segmentation by revenue 2013 and 2014
Exhibit 24: St. Jude: Product segmentation by revenue 2014
Exhibit 25: St. Jude: Product segmentation by revenue 2013 and 2014
Exhibit 26: Coherex Medical: Product offering



【掲載企業】

AtriCure, Boston Scientific, St. Jude, Coherex Medical, Lifetech Scientific, SentreHEART, Occlutech.


【資料のキーワード】

左心耳(LAA)閉鎖デバイス、心房細動、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[左心耳(LAA)閉鎖デバイスの世界市場2016-2020] (Global Left Atrial Appendage (LAA) Closure Market 2016-2020 / IRTNTR7702)販売に関する免責事項
[左心耳(LAA)閉鎖デバイスの世界市場2016-2020] (Global Left Atrial Appendage (LAA) Closure Market 2016-2020 / IRTNTR7702)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆